Collection home page  Journal of Clinical Oncology 2018

RSS Feed


PreviewIssue DateTitleContributor(s)
2018 JoCO Volume 36 Issue 6 February (11).pdf.jpg2018Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast CancerStover, Daniel G; Parsons, Heather A; Ha, Gavin; Freeman, Samuel S; Barry, William T; Guo, Hao; Atish, D; Gydush, Gregory; Reed, Sarah C; Rhoades, Justin; Rotem, Denisse; Hughes, Melissa E; Deborah, A; Partridge, Ann H; Wagle, Nikhil; Krop, Ian E; Getz, Gad; Golub, Todd R
2018 JoCO Volume 36 Issue 6 February (2).pdf.jpg2018Cost Effectiveness of Gene Expression Pro fi le Testing in Community PracticeChandler, Young; Schechter, Clyde B; Jayasekera, Jinani; Near, Aimee; Neill, Suzanne C O; Isaacs, Claudine; Phelps, Charles E; Ray, G Thomas; Lieu, Tracy A; Ramsey, Scott; Mandelblatt, Jeanne S
2018 JoCO Volume 36 Issue 6 February (9).pdf.jpg2018Streamlining Adverse Events Reporting in Oncology : An American Society of Clinical Oncology Research StatementLevit, Laura A; Perez, Raymond P; Smith, David C; Schilsky, Richard L; Hayes, Daniel F; Vose, Julie M
2018 JoCO Volume 36 Issue 9 March (4).pdf.jpg2018Immune-Modi fi ed Response Evaluation Criteria In Solid Tumors ( imRECIST ): Re fi ning Guidelines to Assess the Clinical Bene fi t of Cancer ImmunotherapyHodi, F Stephen; Ballinger, Marcus; Lyons, Benjamin; Soria, Jean-charles; Nishino, Mizuki; Tabernero, Josep; Powles, Thomas; Smith, David; Hoos, Axel; Mckenna, Chris; Beyer, Ulrich; Rhee, Ina; Fine, Gregg; Winslow, Nathan; Chen, Daniel S; Wolchok, Jedd D
2018 JoCO Volume 36 Issue 8 March (6).pdf.jpg2018Quality of Life Outcomes for Cabozantinib Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma : METEOR Phase III Randomized TrialCella, David; Escudier, Bernard; Tannir, Nizar M; Powles, Thomas; Donskov, Frede; Peltola, Katriina; Heng, Daniel Y C; Mainwaring, Paul N; Hammers, Hans J; Lee, Jae Lyun; Roth, Bruce J; Williams, Paul; Baer, John; Mangeshkar, Milan; Scheffold, Christian; Hutson, Thomas
2018 JoCO Volume 36 Issue 9 March (18).pdf.jpg2018How Should We Assess Bene fi t in Patients Receiving Checkpoint Inhibitor Therapy ?Chmielowski, Bartosz; Angeles, California Los; Comprehensive, Jonsson; Angeles, Los
2018 JoCO Volume 36 Issue 9 March (13).pdf.jpg2018Controversies in the Management of Clinical Stage I Seminoma : Carboplatin a Decade in — Time to Start Backing OutWetering, Rune A W Van De; Sleijfer, Stefan; Medical, Erasmus
2018 JoCO Volume 36 Issue 8 March (17).pdf.jpg2018Do Genomic Assays Provide the Necessary Con fi dence to De-escalate Adjuvant Therapy ?Costa, Ricardo L B; Moffitt, H Lee
2018 JoCO Volume 36 Issue 9 March (11).pdf.jpg2018J OURNAL OF C LINICAL O NCOLOGY Through the Glass Ceiling Bertrand Coif fi erSalles, Gilles; Bernard, Claude; Bernard, Claude
2018 JoCO Volume 36 Issue 8 March (21).pdf.jpg2018Targeting HER2 by Combination TherapiesRuiz-saenz, Ana; Francisco, San; Francisco, San
2018 JoCO Volume 36 Issue 8 March (9).pdf.jpg2018Reply to M . Horiguchi et alOf, Ournal
2018 JoCO Volume 36 Issue 8 March (25).pdf.jpg2018No TitleApril, The
2018 JoCO Volume 36 Issue 11 April (4).pdf.jpg2018Quality of Life During Treatment With Chemohormonal Therapy : Analysis of E3805 Chemohormonal Androgen Ablation Randomized Trial in Prostate CancerMorgans, Alicia K; Chen, Yu-hui; Sweeney, Christopher J; Jarrard, David F; Plimack, Elizabeth R; Benjamin, A; Carducci, Michael A; Hussain, Maha; Garcia, Jorge A; Cella, David; Dipaola, Robert S; Linda, J
2018 JoCO Volume 36 Issue 10 April (5).pdf.jpg2018Risk of Synchronous Distant Recurrence at Time of Locoregional Recurrence in Patients With Stage II and III Breast Cancer ( AFT-01 )Neuman, Heather B; Schumacher, Jessica R; Francescatti, Amanda B; Adesoye, Taiwo; Edge, Stephen B; David, J; Yu, Menggang; Mckellar, Daniel; Winchester, David P; Greenberg, Caprice C
2018 JoCO Volume 36 Issue 10 April (2).pdf.jpg2018Placebo-Controlled , Double-Blinded Phase III Study Comparing Dexamethasone on Day 1 With Dexamethasone on Days 1 to 3 With Combined Neurokinin-1 Receptor Antagonist and Palonosetron in High- Emetogenic ChemotherapyIto, Yuka; Tsuda, Takashi; Minatogawa, Hiroko; Kano, Sayaka; Sakamaki, Kentaro; Ando, Masahiko
2018 JoCO Volume 36 Issue 1 January (5).pdf.jpg2018Racial and Ethnic Disparities in Cancer Survival : The Contribution of Tumor , Sociodemographic , Institutional , and Neighborhood CharacteristicsEllis, Libby; Canchola, Alison J; Spiegel, David; Ladabaum, Uri; Haile, Robert; Gomez, Scarlett Lin
2018 JoCO Volume 36 Issue 11 April (20).pdf.jpg2018The Final Verdict : Chemotherapy Bene fi ts Estrogen Receptor – Negative Isolated Local RecurrenceChan, Nancy; Toppmeyer, Deborah Lynn; Cancer, Rutgers; Brunswick, New
2018 JoCO Volume 36 Issue 1 January (14).pdf.jpg2018BRAF V600E Status Alone Is Not Suf fi cient as a Prognostic Biomarker in Pediatric Low-Grade GliomaOf, Ournal
2018 JoCO Volume 36 Issue 10 April (12).pdf.jpg2018Randomized Phase III and Extension Studies of Naldemedine in Patients With Opioid-Induced Constipation and CancerOf, Ournal
2018 JoCO Volume 36 Issue 12 April (11).pdf.jpg2018EML4-ALK Variant Affects ALK Resistance MutationsHospital, Cantonal; Gallen, St